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ABSTRACT
Objective: Strenuous exercise variably modifies
cardiovascular function. Only few data are available on
intermediate levels of effort. We therefore planned a
study in order to address the hypothesis that a half
marathon distance would result in transient changes of
cardiac mechanics, neural regulation and biochemical
profile suggestive of a complex, integrated adaptation.
Methods: We enrolled 35 amateur athletes (42
±7 years). Supine and standing heart rate variability and
a complete echocardiographic evaluation were assessed
on site after the completion of a half marathon
(postrace) and about 1 month after (baseline).
Biochemical tests were also measured postrace.
Results: Compared to baseline, the postrace left
ventricular end-diastolic volume was smaller, peak
velocity of E wave was lower, peak velocity of A wave
higher, and accordingly the E/A ratio lower. The
postrace heart and respiratory rate were higher and
variance of RR interval lower, together with a clear shift
towards a sympathetic predominance in supine position
and a preserved response to orthostasis. At baseline,
athletes were characterised by a lower, although still
predominant, sympathetic drive with a preserved
physiological response to standing.
Conclusions: Immediately after a half marathon there
are clear marks that an elevated sympathetic cardiac
drive outlasts the performance, together with decreased
left ventricular diastolic volumes and slight
modifications of the left ventricular filling pattern
without additional signs of diastolic dysfunction or
indices of transient left or right ventricular systolic
abnormalities. Furthermore, no biochemical indices of
any permanent cardiac damage were found.
INTRODUCTION
The understanding and insight of exercise-
induced cardiovascular modiﬁcations is
nowadays of great interest. It is known that
exercise variably modiﬁes cardiac function
and cardiovascular neural regulation. These
modiﬁcations can widely vary from favourable
and protective to dangerous and hazardous.1
Such a broad range of effects may depend on
individual risk proﬁle on one hand and level
and type of exercise on the other hand. In
the past recent years, studies carried on
amateur athletes have fathomed the effects of
strenuous exercise on cardiovascular func-
tion.2–7 It has been demonstrated that eleva-
tions of cardiac biomarkers after strenuous
endurance exercises can occur in the absence
of sustained myocardial dysfunction.
Conversely, signs of transient left ventricular
(LV) diastolic impairment and/or right ven-
tricular (RV) dysfunction have been detected
in some cases. These reversible and func-
tional changes have been attributed to the
combination of prolonged myocardial work-
load, tachycardia and dehydration secondary
to strenuous exercise.
KEY MESSAGES
▪ The understanding and insight of exercise-
induced cardiovascular modifications is now-
adays of great interest. It is known that marathon
can determine transient elevations in cardiac bio-
markers and echocardiographic evidence of dif-
ferent degrees of cardiac dysfunction. We
therefore planned a study to assess cardiac func-
tion and neural regulation on adult amateur ath-
letes running a shorter distance.
▪ Immediately after a half marathon, we found
signs of an elevated sympathetic cardiac drive,
together with decreased left ventricular diastolic
volumes and slight modifications of the left ven-
tricular filling pattern without additional signs of
diastolic dysfunction, nor of transient left or right
ventricular systolic abnormalities, nor biochem-
ical indices of any permanent cardiac.
▪ Our study implies that a half marathon, although
representing a much less stressful challenge and
not producing major cardiac changes, deter-
mines slight diastolic modifications, whose rele-
vance needs to be investigated. There is also
evidence that a combined evaluation of cardiac
mechanics and neural control may provide more
complete information in guiding individual train-
ing and targets.
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Most investigations are limited to the evaluation of car-
diovascular changes occurring after marathon or ultra-
marathon races that represent an unusually elevated load
to the heart. Only few data are available on relatively
shorter distances, such as those run in a half marathon.8
Although still challenging, it is less demanding, and may
represent a reasonable intermediate level of effort, which
is increasingly followed by growing numbers of partici-
pants, eventually preceding a full marathon engagement.
In addition, to our knowledge there are no studies which
combine on site evaluation of mechanical and neural
response to endurance races. Accordingly, we planned a
study on a group of trained adult amateur athletes in
order to address speciﬁcally the hypothesis that a half
marathon distance would result in transient postrace
changes of cardiac mechanics, neural regulation and bio-
chemical proﬁle suggestive of a complex, integrated
adaptation.
METHODS
Patient population
We enrolled 35 amateur athletes, 4 women and 31 men,
age 42±7 years (range 30–57), body mass index 22.1
±1.6 kg/m2, participating in the ﬁfth Corripavia half
marathon (distance 21 097 km), who volunteered and
provided written, informed consent.
All athletes were healthy and free from pulmonary
and cardiovascular disease and any family history of
early cardiovascular disease and were not taking any pre-
scribed medication.
Protocol
All participants were studied at the end of the half mara-
thon completion (postrace) to measure onsite para-
meters and about 4 weeks after (baseline) to assess
baseline parameters.
Postrace, according to the arrival order, runners were
directed to one of the two stations prepared in front of
the ﬁnishing line, where echocardiographic evaluation,
supine and standing heart rate variability (HRV) assess-
ment and blood sample withdrawal were performed.
Supine brachial blood pressure was measured with a
manual sphygmomanometer. HRV and echocardiog-
raphy were repeated to assess baseline parameters a
month after the race. As only 4 of 35 participants in the
study agreed to repeat blood sample, this was avoided in
all.
There was no ﬂuid restriction during the race. In the
period between the postrace and the baseline tests,
runners were allowed to continue their regular training
but were asked to avoid any race. The day of the baseline
tests, each participant was interviewed to verify adher-
ence to the training schedule (no race allowed) and the
absence of intercurrent disease. On both days all partici-
pants had a caffeine-free breakfast, care was taken to
avoid noise and the ambient temperature was kept com-
fortable during the tests.
Echocardiographic assessment
A comprehensive echocardiographic examination (two-
dimensional (2D), M-mode, Doppler, Tissue Doppler
Imaging (TDI) and 2D Longitudinal Strain (LS)) was
performed in accordance with recommendations from
the American Society of Echocardiography by two
experienced and qualiﬁed sonographers using a com-
mercially available ultrasound system (Vivid 7, GE
Medical, Horton, Norway) and a 1.5–4 MHz phased
array transducer.9 The images were digitally stored and
later analysed ofﬂine using an EchoPAC V.7.0.0 (GE
Vingmed). The presence of signiﬁcant valvular disease
or intracardiac shunts was excluded by means of colour
Doppler. LV end-diastolic volume (EDV) and end-systolic
volume (ESV), as well as biplane LV ejection fraction
(EF), were calculated from four-chamber and two-
chamber images, using the modiﬁed Simpson rule.
Mitral inﬂow measurements were obtained from the
four-chamber view by placing the sample volume at
mitral leaﬂet tips, and early ﬁlling LV velocity (E) and
atrial ﬁlling velocity (A) waves, E/A ratio and E wave
deceleration time (DT) were measured. TDI measure-
ments were assessed in the apical four-chamber view
placing the sample volume at the junction of the inter-
ventricular septum with the mitral anulus. Early (e0) dia-
stolic myocardial velocities were recorded and E/e0 ratio
was calculated. For 2D, TDI and 2DLS measurements
three beats were stored and analysed. Segmental evalu-
ation of peak systolic 2DLS was performed at the basal
and middle levels for all the walls visualised in the four-
chamber, three-chamber and two-chamber apical views.
Values of all segments were averaged to obtain the
global LS.10 All echocardiographic analyses were per-
formed separately and blinded to other participant data
by an experienced echocardiographer.
HRV assessment
ECG was obtained by a modiﬁed II lead conﬁguration.
Respiratory activity was recorded by a thoracic belt con-
nected to a pressure transducer. ECG and respiratory
activity signals were digitised at 300 Hz by an
analog-to-digital board (AT-MIO 16E2, National
Instruments) and stored on the hard disk of a personal
computer for ofﬂine analysis. Signals were continuously
recorded with the participant lying supine for 5 min and
while standing for 4 min.
Analog data were analysed ofﬂine. RR interval (RR)
was calculated as the time distance between two consecu-
tive interpolated parabolic R wave apexes. Software tech-
niques for series extraction, spectral and cross-spectral
analyses of RR and respiratory activity have been
described in detail elsewhere.11 12 Autoregressive spec-
tral analysis provided the power spectrum density of the
low frequency (LF, from 0.03 to 0.15 Hz) and high fre-
quency (HF, above 0.15 Hz) components of the RR
series. These oscillatory components were expressed in
both absolute (ms2 or mm Hg2) and normalised units
(nu).13 Normalisation was obtained dividing the
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absolute power of each component by total variance
(minus the power of the very low frequency component)
and then multiplying by 100.11–14 Spectral indices were
indicated as LFRR, HFRR or LF/HF. LFRR expressed in
nu was utilised as an index of the cardiac sympathetic
oscillatory modulation, HFRR as a marker of the vagal
cardiac oscillatory modulation.12–14 The LFRR/HFRR
ratio quantiﬁed the sympathovagal interaction to the
sinoatrial node.11–14
Biochemical studies
Blood samples were collected in K2EDTA tubes for
blood count and in no additive tubes for serum cardiac
biomarkers, stored in refrigerated transport box (2–8°C)
and arrived at the biochemistry laboratory in about
20 min. On arrival whole blood was analysed for haem-
atological parameters, and serum prepared by centrifu-
gation and analysed thereafter. Creatine kinase (CK) was
determined using an automated analyser (Roche
Modular), and the Roche CK kit (Roche Diagnostics
GmbH, Mannheim, Germany). CK-MB isoenzyme and
troponin I (cTnI) were performed using a one-step
immunoassay sandwich method with a ﬁnal ﬂuorescent
method (ELFA) on a Mini VIDAS (bioMérieux,
Marcy-l’Etoile, France). The CK assay normal range was
38–174 U/L for men and 26–140 U/L for women, and
the CK-MB assay detection limit was 6.8 ng/mL.
The cTnI assay detection limit was 0.01 μg/L, with the
clinical cut-off level for myocardial infarction set at
0.03 μg/L.15
Statistical analysis
All the participants who volunteered were enrolled and
analysed. Data are expressed as mean±SD. The signiﬁ-
cance of the differences between echocardiographic
parameters (see list in table 1) was assesses via paired
two-sided t test. If the normality test was not fulﬁlled
according to a Kolmogorov-Smirnov test with p<0.05,
Wilcoxon-signed rank test was applied. The signiﬁcance
of the differences between HRV parameters at baseline
and postrace, measured in supine position and while
standing (see list in table 2) was evaluated using two-way
repeated measures analysis of variance with the
Holm-Sidak post hoc test. We assessed the effect of race
within the same experimental condition (ie, supine or
standing) and the effect of the modiﬁcation of posture
within the same period of analysis (ie, postrace or base-
line examination). The appearance of cTnI in the sys-
temic circulation above assay detection levels was
analysed descriptively as it was reported only in one
case. A p<0.05 was considered signiﬁcant. All analyses
were carried out on SPSS (Statistical Package for Social
Sciences, Chicago, Illinois, USA), V.17.0.
RESULTS
All 35 enrolled runners ﬁnished the race, were ambula-
tory, and reported no signs or symptoms of (pre)
syncope or cardiovascular impairment. None required
medical attention.
Race started at 9:00, the average ﬁnish time was
96 min and 30 s (range 7805500 to 11904200). Weather con-
ditions were mild with mean temperature of 15°C.
The time from cessation of running to onsite HRV
and echocardiographic assessments was similar among
all runners (15–20 min). The time from the race day to
the baseline tests was 30±8 days.
Compared to baseline, as expected, postrace supine
HR was higher by 22±14 bpm (p<0.05) and supine sys-
tolic arterial pressure lower by 13±8 mm Hg (p<0.05;
table 1).
Postrace and baseline echocardiographic parameters
Echocardiographic parameters are shown in table 1.
Compared to baseline, postrace LVEDV was smaller by
11.63±3.82 mL (p<0.05), while LVESV, LV mass, as well
as the indices of LV systolic function, including
assessment of regional wall motion by TDI and 2DLS
(ﬁgure 1) were similar. Aortic root diameter, left atrial
areas, RV dimension and systolic function were also
unchanged. Peak velocity of E wave was found lower by
0.7±4.6 m/s, peak velocity of A wave was found higher by
Table 1 Descriptive statistics of echocardiographic
variables of amateur athletes assessed 1 month after the
race (baseline) and on site after the half marathon
completion (postrace)
Baseline Postrace
HR (bpm) 63±12 86±14*
SAP (mm Hg) 121±8 108±8*
LV EDV (cm3) 117±24 105±23*
LV ESV (cm3) 43±11 41±14
LV EF (%) 62±6 62±7
LV mass index (g/m2) 177±46 164±41
GLS (%) −20±3 −19±3
Aortic root diameter (mm) 32±3 26±3
Max LA area (cm2) 15±3 14±2
Min LA area (cm2) 8±2 8±2
RVOT prox (mm) 30±3 29±3
RVI diameter (mm) 33±2 32±3
TAPSE (mm) 23±1 24±1
E (m/s) 0.74±0.13 0.67±0.15*
A (m/s) 0.52±0.13 0.63±0.15*
E/A ratio 1.5±0.36 1.08±0.18*
DT (ms) 211.22±38.47 198.46±41.8
E0 (cm/s) 10.07±1.4 9.29±2.1
E/e0 ratio 7.39±1.09 7.41±1.8
ICV diameter (mm) 20±2 20±3
Data represent mean±SD, *p<0.05 postrace versus baseline.
A, mitral A wave filling velocity; DT, mitral deceleration time; e0,
early diastolic myocardial velocity; E, mitral E wave filling velocity;
EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic
volume; GLS, global longitudinal strain; HR, heart rate; ICV,
inferior cava vein; LA, left atrium; LV, left ventricular; RVI, right
ventricular inflow; RVOT prox, right ventricular outflow tract
proximal diameter; SAP, systolic arterial pressure; TAPSE,
tricuspid anular plane systolic excursion.
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15.6±3.5 m/s, and accordingly the E/A ratio lower by
0.29±0.09 (p<0.05), while DT, e0 and E/e0 ratio were
analogous. The inferior cava vein (ICV) diameter was
similar in both conditions with a preserved >50%
inspiratory collapse reﬂecting normal central venous
pressure.
Postrace and baseline HRV
HRV data are shown in table 2. At baseline, athletes
demonstrated signs of sympathetic predominance when
supine with a preserved excitatory physiological response
to standing, as HR increased by 11±1 bpm, LFRR
increased by 21±3 nu and HFRR decreased by 19±3 nu,
and accordingly LF/HF ratio increased by 12±4 (p<0.05;
table 2, ﬁgure 2). Compared to baseline, as expected,
postrace HR and respiratory rate were higher (p<0.05),
while variance of RR was lower (p<0.05). Postrace auto-
nomic proﬁle was also characterised by other signiﬁcant
differences compared to baseline. Indeed, we observed a
clear shift towards higher indirect indices of prevailing
sympathetic modulation in supine position (LFRR higher
by 19±4 nu and HFRR lower by 31±5 nu, postrace vs
baseline; p<0.05) despite an HR in normal range. The
postrace response to orthostasis was still clear, as HR
increased by 10±1 bpm, LFRR increased by 10±2 nu and
HFRR decreased by 5±2 nu, and accordingly LF/HF ratio
increased by 11±4 (p<0.05; table 2, ﬁgure 2).
Postrace biochemical parameters
Postrace, mean blood levels for haemoglobin and haem-
atocrit resulted within normal limits (14.8±1.1 g/dL and
43.3±2.9%, respectively). Mean white cell count was 14.14
±3.9×10^9/L with a range from normal to abnormally
high values (from 8.9 to 23.3×10^9/L). Value above
normal limits were present in 26 athletes (74%), while
the remaining showed normal values (15.5±3.4×10^9/L,
range 10.6–23.3×10^9/L and 9.4±0.4×10^9/L, range 8.9–
10.2×10^9/L, respectively). Postrace, CK was above
normal limits in all participants with a mean value of
320.3±176.3 U/L, range 121–913 U/L, while CK-MB was
above normal limits only in 16 of 35 participants. In this
latter group mean CK-MB was 9.6±2 ng/mL (range 6.9–
15.9 ng/dL), while in the remaining 19 participants it
was 4.2±1.3 ng/dL (range 1.8–6.3 ng/dL). Detectable
Table 2 Descriptive statistics of heart rate variability indices assessed 1 month after the race (baseline) and on site after the
half marathon completion (postrace)
Baseline Postrace
Supine Standing Supine Standing
HR (bpm) 63±12 74±16** 86±14* 97±16*,**
Resp (cycles/min) 16±3 15±1 18±1* 19±1*
RR (ms) 993±183 842±168** 730±127* 643±110*,**
σ2RR (ms
2) 3874±788 3044±852 1567±586* 1671±823*
LFRR (ms
2) 1026±113 1455±319 1001±448 1431±148
LFRR (nu) 59±12 81±16** 76±13* 86±10**
HFRR (ms
2) 646±130 357±45 132±97* 178±88
HFRR (nu) 37±22 17±6** 14±9* 8±7*,**
LF/HR ratio 3±3 15±4** 11±2* 34±4**
Data represent mean±SD, *p<0.05 postrace versus baseline; **p<0.05 standing versus supine.
σ2RR, variance of RR variability; HFRR, high-frequency power of RR variability; HR, heart rate; LFRR, low-frequency power of RR variability; nu,
normalised units; RR, R–R interval; Resp, respiratory activity.
Figure 1 An exemplar scan from tissue-Doppler assessment of regional wall strain in the apical four-chamber view measured at
the basal and at the mid-wall level of the septum and lateral wall obtained in an amateur athlete immediately after the completion
of the half marathon (postrace, left panel) and 1 month after (baseline, right panel).
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cTnI was observed only in one 32-year-old male athlete
(0.45 μg/L), who did not show any difference for the
echocardiographic and HRV parameters compared to
the other runners either postrace or at baseline.
DISCUSSION
The major ﬁnding of this study was that immediately
after a half marathon there are clear signs that an ele-
vated sympathetic cardiac drive outlasts the perform-
ance, together with decreased LV diastolic volumes and
slight modiﬁcations of the LV ﬁlling pattern without
additional signs of diastolic dysfunction. Neither echo-
cardiographic nor biochemical indices of any perman-
ent cardiac damage, nor indices of transient or RV
systolic abnormalities were found.
Postrace echocardiographic findings
Previous studies have demonstrated that after a mara-
thon challenge transient cardiac diastolic dysfunction
can occur in some cases, possibly due to an excessive
load to the heart.2–7 In addition, the more intense the
exercise load, the higher the cardiac mechanical suscep-
tibility and more persistent the diastolic dysfunction of
both the LV and the RV.2 4 16 In our study after a half
marathon, which represents a much less stressful chal-
lenge, we detected a decreased LV diastolic volume and
a decrease in the E/A ratio, although still within the
normal ranges (>1), due to a decrease of the E wave and
an increase of the A wave. Other and more sophisticated
measures of LV diastolic properties, such as DT, E0 wave,
E/e0 ratio, LA size and reservoir, were not different from
values observed at baseline. The E wave is known to be
preload dependent, and the A wave dependent on heart
rates and volume loads.17–21 Indeed, the A wave ampli-
tude may be elevated during higher heart rates because
of the merging of the E and A wave17 18 21 and because
of the presence of smaller LVEDV.17 20 21 This latter
ﬁnding can be consequent to a reduced preload result-
ing from postexercise redistribution of blood to the
Figure 2 Examples of power spectrum analyses of RR and RESP in an amateur athlete (same participant as in figure 1) few
minutes after the completion of the half marathon (postrace, left panels) and 1 month after (baseline, right panels) at rest (top
panels) and during standing (bottom panels). Baseline autonomic profile is characterised by sympathetic predominance at rest
both postrace (left top panel) and at baseline (right top panel). In both conditions the physiological excitatory response to
orthostasis is preserved (bottom panels). a.u., arbitrary units; PSD, power spectrum density; RESP, respiratory activity; RR, R–R
interval.
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periphery.21 Reduced preload might also depend on
dehydration-induced decrements in central blood
volume, although in our middle-distance marathoners
there were no signs of signiﬁcantly reduced central
venous pressure as assessed by ICV diameter and collaps-
ibility. The impact of acute exercise on diastolic function
could also be viewed as a process of augmentation to
underpin increases in LV systolic function18 19 or
decreases in RV systolic function.8 Therefore, the iso-
lated modiﬁcation of the transmitral inﬂow pattern
might reﬂect an adaptation to the postexercise haemo-
dynamic changes rather than intrinsic alterations in LV
relaxation or compliance properties.17–20 On the other
hand, diastolic modiﬁcations might reﬂect reduced lusi-
tropic properties for instance as a residual postexercise
altered sodium-calcium handling.22 Despite speculation
at the moment there is no evidence to support any of
these competing theories. This requires further study in
a range of different populations.
In keeping with previous investigations,2–7 the echocar-
diographic indices of regional and global systolic func-
tion were normal at baseline and unchanged postrace.
Importantly, strain analysis provided an objective
measure of preserved segmental LV systolic shortening.
As previously demonstrated these indices have excellent
feasibility and reproducibility,10 23 are considered super-
ior to LVEF and visual wall motion assessment for pre-
diction of mortality,24 and have been recently
demonstrated as accurate indicators for patients with a
potential for substantial myocardial damage.25
We therefore demonstrated that after a half marathon
not only the LV systolic function is preserved, but also
that only minor signs of diastolic impairment are detect-
able. Indeed, the reduced load imposed by the half
marathon distance as compared to a full marathon,
seems to preserve the heart from excessive stress and
major diastolic impairment.
Postrace autonomic cardiac control
Spectral analysis of short-term HRV has been shown to
be capable of detecting the complex adaptive changes
in sympathovagal balance attending various aspects of
exercise and recovery in athletes.26–28 In the volunteers
of the present study we found at baseline a supine spec-
tral proﬁle characterised by a slight predominance of
LFRR expressed in nu, in the presence of heart rates in
the low-normal range (63±12 bpm), as observed in well-
trained, near competition athletes.27 Postrace, immedi-
ately after the completion of the half marathon, that is,
after a heavy bout of acute exercise, an even more pro-
nounced predominance of indirect indices of sympa-
thetic modulation to the heart was present in the supine
position despite, again as expected in athletes, the heart
rate, although higher than at baseline, was still in the
normal range (86±14 bpm). Previous studies have
demonstrated that training leads to an array of possible
sympathovagal adjustments, that is, regular training at
intermediate load leads to training bradycardia and
vagal predominance,29 while a strenuous training for
getting ready to competition enhances sympathetic
modulation.26 27 Signs of elevated sympathetic modula-
tion have even been correlated to faster marathon
arrival time.30 31
It is noteworthy that, either at baseline or postrace,
our athletes showed a physiological and adequate
response to orthostasis, further supporting the notion of
a physiological rather than pathological response in our
population.
Biomarkers
As baseline biochemistry was not assessed we may only
suggest some comments regarding postrace biochemical
ﬁndings.
High levels of leucocytes were detected in 74% of our
non-elite runners after the half marathon completion. It
has been previously reported that acute strenuous exer-
cise can be associated with transient leucocytosis, fol-
lowed by complete normalisation after 24 h, although its
signiﬁcance has not been completely understood.32
Conversely, levels of haemoglobin and haematocrit
were found within normal ranges. These ﬁndings,
together with normal ICV diameters and collapsibility,
suggest that, on the whole, signiﬁcant dehydration did
not develop during the race.
CK was elevated in all participants. Although CK is not
cardiac speciﬁc, it parallels the strenuous nature of a half
marathon. Regarding markers of myocardial injury,
CK-MB was high in 46% of our athletes, while all, but
one, were characterised by normal levels of cTnI after the
race, further supporting the interpretation that the half
marathon may represent a limited load. Indeed, previous
investigations have reported increased levels of CK-MB
and troponins in elite and non-elite athletes following
the completion of marathon events,2 33–35 that is, a
double distance than the one we tested in the present
study, and correlated with the increased endurance
time.2 This hypothesis is in accordance with our results,
as we can speculate that a longer distance might increase
the number of participants with positive biomarkers.
Anyhow, it has been demonstrated that the postexercise
troponin release does not correspond to true myocardial
necrosis.3 5 8 34 It may represent reversible cardiomyocyte
membrane damage due to an excessive cardiac load, as it
is not associated with any sustained alterations of echocar-
diographic parameters of systolic, diastolic or right-sided
heart dysfunction, as it was the case in our athletes.
Notably, the racer in our study with slight elevation of
cTnI was healthy, well-trained and still running competi-
tions at a 2-year follow-up.
Limitations
Our study has several limitations mainly due to the
impossibility to standardise experimental conditions,
such as ﬂuid intake during the race or level of training
for a baseline evaluation. In addition, we limited the
number of echocardiographic and HRV measures in
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order to allow a similar and as fast as possible postrace
on site evaluation. For example, HRV was not integrated
by the beat-to-beat blood pressure variability assessment
and echocardiographic RV assessment was partial.
Finally, the lack of baseline biomarkers limits the inter-
pretation of such variables. However, combining the
evaluation of cardiac mechanics and neural control may
represent a key to a better understanding of those
important adaptational processes that are engaged to
different levels of exercise challenge.
Implications for clinical practice
While regular physical activity is clearly a positive deter-
minant of longevity in recreational athletes and former
endurance athletes and is associated with an improved
cardiovascular risk proﬁle,1 debate exists on the level of
exercise to be recommended at different ages and in
the presence of cardiovascular risk and/or diagnosed
cardiovascular disease.1 36 37 The intensity of exercise is
also a key issue in cardiac rehabilitation.38
Indeed exercise in general can be considered a
therapy and its beneﬁcial effects overcome potential
risks when correctly prescribed.
Former studies have demonstrated that marathon and
ultramarathon can determine elevations in cardiac bio-
markers and echocardiographic evidence of different
degrees of cardiac dysfunction, and thus they may repre-
sent a potentially dangerous load.2–7 However, it has
been suggested that appropriate training and prepar-
ation play an important protective role against excessive
endurance exercise loads.2 17
Our study implies that a half marathon, although
representing a much less stressful challenge and not pro-
ducing major cardiac changes, still determines slight dia-
stolic modiﬁcations, whose relevance needs to be
investigated. There is also evidence that a combined
evaluation of cardiac mechanics and neural control may
provide more complete information in guiding individ-
ual training and targets.
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